MedTech Innovator LIVE

Doug Portnow is a partner in the Palo Alto office of Wilson Sonsini Goodrich & Rosati, where he focuses his practice on patent prosecution and counseling. He regularly works with inventors to prepare new patent applications, and to draft amendments in response to office actions from the U.S. Patent and Trademark Office. Doug is also experienced in patentability, validity, and freedom-to-operate studies. He has worked extensively in the medical device and surgical sectors, including interventional cardiology, vascular surgery, and orthopedics, as well as with more traditional mechanical inventions.

Doug has worked actively with a number of start-up companies to help develop their intellectual property portfolios as well. He has performed due diligence work for numerous clients during venture financing and M&A activities, with many of these companies successfully raising capital or being acquired by public companies.

Prior to joining the firm, Doug was an associate in the mechanical and medical device group at Townsend and Townsend and Crew LLP (now Kilpatrick Townsend & Stockton). Before entering the legal profession, he worked for more than a decade in the medical device industry. He also held positions in engineering and senior management at start-up companies and well-established medical manufacturers located both within the U.S. and overseas.

Uri Greenwald, M.D., is an associate in the San Diego office of Wilson Sonsini Goodrich & Rosati, where he leverages his background and expertise as a trained physician and general surgeon to build strong, valuable patent portfolios for medical device, pharmaceutical, and life science companies at all stages of growth and development.

Uri has trained at some of the country’s busiest hospitals, including Bellevue Hospital, Kings County Hospital, and the Interim Charity Hospital of New Orleans. In addition, he has conducted clinical and bench research with leading physician scientists in the medicine and surgery departments of the New York University School of Medicine.

Doug Limbach is a partner at Shay Glenn LLP where he counsels technology companies and investors, primarily in the medical device industry. Doug entered the field of intellectual property law in 1991 as a patent agent and later an associate at Limbach & Limbach, LLP where he was trained in patent preparation, prosecution, opinion writing, licensing, litigation, mediation and strategic portfolio management. In 2001, he founded Synchroscan Corporation, which developed a line of wireless telecommunications products. Doug later served as Director of Intellectual Property at medical device company TheraSense / Abbott Diabetes Care, and Senior Counsel at microelectromechanical systems company Form Factor. He returned to private practice as Of Counsel, first at general practice law firm Greenberg Traurig and then at life sciences IP firm Bozicevic, Field & Francis. Prior to entering the legal profession, Doug was a design engineer for six years in the fields of automated machinery, precision mechanisms and medical equipment development.

Doug received a Bachelors of Science in Mechanical Engineering with an emphasis in robotics from the University of Colorado, and holds a Professional Engineers License in California. Doug earned his J.D. degree from Golden Gate University School of Law, where he was a judicial extern in U.S. District Court for Chief Magistrate Judge F. Steele Langford. He is admitted to practice in California and before the U.S. Patent and Trademark Office.

Doug was the 83rd President of the San Francisco Intellectual Property Law Association and served on its Board of Directors from 2005 to 2010.